Trials / Recruiting
RecruitingNCT06981208
ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 410 (estimated)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study, patients who are scheduled for breast reconstruction consultation will be randomized into the intervention group (ChatGPT-generated patient education regarding possible reconstruction options) or the control group (usual patient education). All patients will complete a survey following their in-person consultation to assess their experience and overall satisfaction with the consultation process. Additionally, participating surgeons will complete a separate survey to evaluate their consultation experience, satisfaction, and to assess the accuracy and clinical utility of the ChatGPT-generated patient education materials. The surveys are designed to gather information on patient characteristics, organizational health literacy according to Brega et al. Other survey questions have been designed to meet the outcomes of this study and have not been based on previously published surveys.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | ChatGPT-generated patient education | This is created by entering the patient's age, medical history, social history, and case-specific details into Washington University ChatGPT Beta (HIPAA and FERPA compliant) by a study team member. |
| OTHER | Usual patient education | Usual patient education will include description of breast reconstruction options, with further elaboration on which option are more suitable to the patient. This include also review of risk of complications and expected recovery after surgery. |
Timeline
- Start date
- 2025-06-03
- Primary completion
- 2026-06-30
- Completion
- 2026-06-30
- First posted
- 2025-05-20
- Last updated
- 2025-06-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06981208. Inclusion in this directory is not an endorsement.